Hosted on MSN20d
EC approves GSK’s Jemperli-chemo combo for endometrial cancer
The European Commission (EC) has approved GSK's Jemperli (dostarlimab) combined with chemotherapy that includes carboplatin and paclitaxel for the first-line treatment of primary advanced or ...
Nasdaq21d
GSK: European Commission Expands Jemperli Plus Chemotherapy Approval - Quick Facts
(RTTNews) - GSK plc (GSK, GSK.L) announced the European Commission has approved Jemperli in combination with chemotherapy for first-line treatment of adult patients with primary advanced or ...